Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2164174

CC(Nc1ncnc2[nH]cnc12)c1cc(F)c2ccnnc2c1-c1cc(F)cc(F)c1.O=C(O)C(F)(F)F

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 16/20 0.49
BCL2 P10415 1/20 0.44
PDPK1 O15530 1/20 0.35
RPS6KB1 P23443 1/20 0.35
PIK3CB P42338 1/20 0.34
AXL P30530 1/20 0.32
MERTK Q12866 1/20 0.32
EGFR P00533 1/20 0.32
HDAC3 O15379 1/20 0.31
ERBB2 P04626 1/20 0.31
KDR P35968 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC7 Q8WUI4 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC10 Q969S8 1/20 0.31
HDAC11 Q96DB2 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
HDAC9 Q9UKV0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2018069 0.93 PIK3CD (0.55) PIK3CDBCL2PDPK1RPS6KB1PIK3CB
SCHEMBL2015977 0.85 PIK3CD (0.66) PIK3CDBCL2PIK3CBAXLMERTK
SCHEMBL2017994 0.85 PIK3CD (0.55) PIK3CDBCL2PDPK1RPS6KB1PIK3CB
Trifluoroacetic Acid SCHEMBL2050996 0.85 PIK3CD (0.57) PIK3CDBCL2PIK3CBAXLMERTK
SCHEMBL2012482 0.84 PIK3CD (0.67) PIK3CDBCL2PIK3CBAXLMERTK
Trifluoroacetic Acid SCHEMBL2052496 0.81 PIK3CD (0.35) PIK3CDPDPK1RPS6KB1
Trifluoroacetic Acid SCHEMBL2164086 0.81 PIK3CD (0.58) PIK3CDPDPK1RPS6KB1PIK3CBMERTK
SCHEMBL2012816 0.81 PIK3CD (0.59) PIK3CDBCL2PDPK1RPS6KB1PIK3CB
SCHEMBL2164179 0.79 PIK3CD (0.41) PIK3CDBCL2PDPK1RPS6KB1
Trifluoroacetic Acid SCHEMBL9929278 0.78 PIK3CD (0.45) PIK3CDBCL2PIK3CBAXLMERTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680108-B2 Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors INCYTE CORPORATION (US) 2014-03-25 US disclosed
US-20110183985-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION 2011-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183985-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS PIK3R1, PIK3R3, PIK3R2 PIK3CD 13/4885BCL2 1174/4885PDPK1 34/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.